Once again let's review the status of the PMCPA review in the U.K. where no written finding has been released yet. Nor has Bourla been fined.
Of course -- as usual -- you are quoting such a shiat source that you are unwilling to provide a link to it.
First, let's outline the anti-vax group UsForThem associated with the initial article you pushed about the PMCPA situation -- noting that UsForThem is the set of anti-vax clowns who filed the complaint with the PMCPA -- most of which has been dismissed already.
UsForThem is the group that created fake consent forms in the U.K. pretending to be from the NHS as well as handing out flyers with fake claims about vaccination in front of schools. This -- of course -- was when they were not sending fake legal summons to claiming crimes against humanity, etc. to school officials supporting vaccination. Currently the UsForThem group is pushing the Died Suddenly film which is completely filled with misinformation.
UsForThem is so twisted in their anti-vax misinformation that the British Medical Journal published a paper documenting them - Understanding and neutralising covid-19 misinformation and disinformation.
Secondly, let's note the primary "charges" against Pfizer CEO Bourla were DISMISSED by the PMCPA. Note the PMCPA has not published the results of their investigation on the final allegation regarding "disgracefully misleading claims" yet. Nothing has been substantiated. The article quoted by Becker is based on a leak to The Daily Telegraph.
Let's go to a reputable source that covers the pharmaceutical industry - Fierce Pharma and read the second half of their article about this matter.
But Pfizer hit back and had appealed against the rulings. In the end, the PMCPA overturned most of the serious breaches, according to The Telegraph.
The way this news has come out is unusual. The PMCPA is self-regulatory body set up by the pharma industry, but it can and does enact some strict punishments if companies are found in breach of its marketing rules. In more serious cases, the findings are published in medical journals.
These cases are always uploaded onto the PMCPA’s site and, when completed, are available for the public to read. But the Pfizer cases—officially titled: AUTH/3591/12/21 - A complaint on behalf of UsForThem v Pfizer—is as yet not completed.
It appears as if the details have been shared with The Telegraph ahead of time but with no one else, which is not usual practice. The PMCPA told Fierce Pharma Marketing it could not say how or why this information had been seen by The Telegraph but a spokesperson said that they "anticipate that the case report will be published on our website before Christmas."
“We are pleased the UK’s PMCPA Appeal Board found Pfizer to have maintained high standards and upheld confidence in our industry, the two most serious rulings in this complaint from a UK campaign group,” a Pfizer spokesman told Fierce Pharma Marketing.
“In the U.K., we have always endeavoured to follow the principles and letter of our industry Code of Practice throughout. We will review the case report in detail when we receive it, to inform future activity.”
